Minerva Neurosciences

NERVNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$198.934 M

$4.27 -3.83%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$293.4M

Loss-making

Shares outstanding

47,747,559

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#266Satellos BioscienceMSLE$208.9M
#267NovaBridge BiosciencesNBP$201.9M
#268Minerva NeurosciencesNERV$198.9M
#269PepGenPEPG$197.1M
#270ImmunicIMUX$194.8M

Where these numbers come from

Share counts and financials for Minerva Neurosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.